CIRM Schedules Action on New Directions for May
Directors of the California stem cell agency last week curtailed discussion of recommendations for changes in the agency's direction, including stronger ties with the biotech industry, putting off the matters until their May meeting.
At last Thursday's meeting, CIRM President Alan Trounson quickly ran through his agency's response to the proposals last …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.